Vivos Therapeutics, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Vivos Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2020 to Q1 2024.
  • Vivos Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $100K, unchanged year-over-year.
  • Vivos Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending March 31, 2024 was $100K, unchanged year-over-year.
  • Vivos Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $100K, unchanged from 2022.
  • Vivos Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $100K, a 66.7% decline from 2021.
  • Vivos Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $300K, a 25% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $100K $100K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $100K -$200K $0 0% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-07-30
Q3 2023 $100K $100K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $100K $100K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-16
Q1 2023 $100K $100K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-06-08
Q4 2022 $100K -$200K -$200K Oct 1, 2022 Dec 31, 2022 10-K/A 2024-07-30
Q3 2022 $300K $100K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $300K $100K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-16
Q1 2022 $300K $100K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-08
Q4 2021 $300K $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $100K Jul 1, 2021 Sep 30, 2021 10-Q 2022-12-20
Q2 2021 $100K -$4.76K -4.54% Apr 1, 2021 Jun 30, 2021 10-Q 2022-12-20
Q1 2021 $100K -$4.76K -4.54% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-11-25
Q2 2020 $105K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $105K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.